Intimation for Business Responsibility and Sustainability Report for the financial year 2025-26

Ref: BHL/STEX 32/2026-27 Date: August 29, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza, Dalal Street Bandra Kurla Complex Bandra (East) Mumbai – 400 001 Mumbai-400051 Scrip Code: 539872 Symbol: BAJAJHCARE Subject: Business Responsibility and Sustainability Report FY 2025-26 Dear Sir/Madam, Pursuant to Regulation 30 & 34(2)(f) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, please find enclosed herewith Business Responsibility and Sustainability Report (“BRSR”), which forms an integral part of the Annual Report of the Company for the financial year 2025-26. The BRSR is also available on the website of the Company at www.bajajhealth.com Kindly take the above information on your record. Thanking you, Yours Faithfully, For and on behalf of Bajaj Healthcare Limited Monica Tanwar Company Secretary & Compliance Officer Encl: as above BAJAJ HEALTHCARE LIMITED Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604 Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com CIN No. L99999MH1993PLC072892 Bajaj Healthcare Limited Annual Report FY 2025-26 Business Responsibility and Sustainability Report SECTION A: GENERAL DISCLOSURES I. Details of the listed entity 1 Corporate Identity Number (CIN) of L99999MH1993PLC072892 the Company 2 Name of the Listed Entity Bajaj Healthcare Limited (“BHCL”) 3 Year of Incorporation 1993 4 Registered Office address 602-606, Bhoomi Velocity Infotech Park, Plot No. B-39, B-39A, B-39 A/1, Rd No.23, Wagle Ind. Estate, Thane West Thane MH 400604 5 Corporate address 602-606, Bhoomi Velocity Infotech Park, Plot No. B-39, B-39A, B-39 A/1, Rd No.23, Wagle Ind. Estate, Thane West Thane MH 400604 6 E-mail ID investors@bajajhealth.com 7 Telephone +91 22 6617 7400 8 Website www.bajajhealth.com 9 Financial Year for which reporting is FY 2025-2026 being done 10 Name of the Stock Exchange(s) - National Stock Exchange of India Limited where shares are listed - BSE Limited 11 Paid-up Capital Rs. 16,83,13,305 12 Name and contact details Name- Ms. Monica Tanwar (telephone, email address) of the Designation- Company Secretary & Compliance Officer person who may be contacted in Email- investors@bajajhealth.com case of any queries on the BRSR Telephone- +91 22 6617 7400 Report 13 Reporting boundary - Are the The disclosures presented in this Business Responsibility and Sustainability Report disclosures under this report made (BRSR) have been prepared on a standalone basis and cover the business operations on a standalone basis (i.e., only for of Bajaj Healthcare Limited (BHL) only. The report does not include the performance the entity) or on a consolidated or disclosures of any subsidiaries, joint ventures, associates or other entities forming basis (i.e., for the entity and all the part of the consolidated financial statements. entities which form a part of its consolidated financial statements taken together) 14 Name of assurance provider Not Applicable for the current reporting year. Assurance will be obtained in the year of 15 Type of assurance obtained applicability, as required. II. Products/services 16. Details of business activities (accounting for 90% of the turnover): S. Description of Main Activity Description of Business Activity % of Turnover No. of the entity 1 Manufacture of Pharmaceuticals Manufacturing & Sale of branded Pharmaceutical Products 100% 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover): S. Product/Service NIC Code % of Total turnover contributed 1 Pharmaceutical Products 242 100% Company Overview Statutoty Reports Financial Statements III. Operations 18. Number of locations where plants and/or operations/offices of the entity are situated: Location Number of Sites Number of offices Total National 6 1 7 International - - - 19. Markets served by the entity: a. Number of locations Locations Number National (No. of States) PAN India International (No. of Countries) 62+ b. What is the contribution of exports as a percentage of the total turnover of the entity? BHL continued to cater to international markets through its export operations during FY 2025-26, supplying pharmaceutical products to customers across regulated and semi-regulated geographies. Export sales contributed approximately 31% of the Company’s total turnover during the reporting year. c. A brief on types of customers BHL serves a diversified customer base across the pharmaceutical and healthcare value chain. Our customers include pharmaceutical manufacturers, formulation companies, contract development and manufacturing organizations (CDMOs), nutraceutical companies and institutional buyers requiring high-quality Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates and finished dosage formulations. We also cater to customers in domestic as well as international markets, including regulated and semi-regulated geographies, through our export business. IV. Employees 20. Details at the end of Financial Year: a. Employees and Workers (including differently abled): S. Particulars Total (A) Male Female No. No. (B) % (B / A) No. (C) % (C / A) EMPLOYEES 1. Permanent (D) 814 736 90.42% 78 9.58% 2. Other than Permanent (E) 70 60 85.71% 10 14.29% 3. Total employees (D + E) 884 796 90.05% 88 9.95% WORKERS 4. Permanent (F) 135 135 100% 0 0% 5. Other than Permanent (G) 0 0 0% 0 0% 6. Total workers (F + G) 135 135 100% 0 0% b. Differently abled Employees and Workers: S. Particulars Total (A) Male Female No. No. (B) % (B / A) No. (C) % (C / A) DIFFERENTLY ABLED EMPLOYEES 1. Permanent (D) 0 0 0% 0 0% 2. Other than Permanent (E) 0 0 0% 0 0% 3. Total differently abled employees (D + E) 0 0 0% 0 0% DIFFERENTLY ABLED WORKERS 4. Permanent (F) 0 0 0% 0 0% 5. Other than Permanent (G) 0 0 0% 0 0% 6. Total differently abled workers (F + G) 0 0 0% 0 0% Bajaj Healthcare Limited Annual Report FY 2025-26 21. Participation/Inclusion/Representation of women Total (A) No. and percentage of Females No. (B) % (B / A) Board of Directors* 10 3 30% Key Management Personnel** 6 2 33.33% *Board of Directors consists of 5 Non-Executive Independent Director, 1 Chairman & Managing Director, 1 Managing Director, 2 Whole time Directors, 1 Non-Executive Non-Independent Director. **Key Management Personnel includes 2 Managing Directors, 2 Whole Time Directors, Company Secretary and Chief Financial Officer. 22. Turnover rate for permanent employees and workers (Disclose trends for the past 3 years) FY 2025-26 FY 2024-25 FY 2023-24 (Turnover rate (Turnover rate (Turnover rate in the year in current FY) in previous FY) prior to the previous FY) Male Female Total Male Female Total Male Female Total Permanent Employees 32.37% 43.21% 33.39% 3.2% 4.6% 3.9% 20% 39% 21% Permanent Workers 1.48% 0% 1.48% 0.9% 0.6% 0.7% 8% 0% 8% V. Holding, Subsidiary and Associate Companies (including joint ventures) 23. (a) Names of holding / subsidiary / associate companies / joint venture S. Name of the holding/ Indicate whether % of shares Does the entity indicated at column No. subsidiary/ associate holding/ Subsidiary/ held by A, participate in Business companies/ joint Associate/ Joint listed entity Responsibility initiatives of the listed ventures (A) Venture entity? (Yes/No) The Company has no Holding, Subsidiary, Associate Companies or Joint Venture. VI. CSR Details 24. (i) Whether CSR is applicable as per section 135 of Companies Act, 2013: Yes a. Turnover (in Rs.) – Rs. 611,03,13,800 b. Net worth (in Rs.) – Rs. 533,00,23,000 VII. Transparency and Disclosures Compliances 25. Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible Business Conduct: Stakeholder Grievance Redressal FY 2025-26 FY 2024-25 group from Mechanism in Place Current Financial Year Previous Financial Year whom complaint ( [Showing first 8,000 characters — download PDF for full document]